J. Moynard

Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas

P. Chevallier, P. Moreau, A. Moreau, 2017, Annals of Hematology.

Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters

C. Guttmann, H. Weiner, S. Khoury, 2006, Journal of Neuroimmunology.

Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients.

D. Laplaud, S. Brouard, J. Soulillou, 2010, Clinical immunology.